期刊文献+
共找到9,689篇文章
< 1 2 250 >
每页显示 20 50 100
Drainage of ascites in cirrhosis
1
作者 Jia-Xing Yang Yue-Ming Peng +2 位作者 Hao-Tian Zeng Xi-Min Lin Zheng-Lei Xu 《World Journal of Hepatology》 2024年第9期1245-1257,共13页
For cirrhotic refractory ascites,diuretics combined with albumin and vasoactive drugs are the first-line choice for ascites management.However,their therapeutic effects are limited,and most refractory ascites do not r... For cirrhotic refractory ascites,diuretics combined with albumin and vasoactive drugs are the first-line choice for ascites management.However,their therapeutic effects are limited,and most refractory ascites do not respond to medication treat-ment,necessitating consideration of drainage or surgical interventions.Con-sequently,numerous drainage methods for cirrhotic ascites have emerged,including large-volume paracentesis,transjugular intrahepatic portosystemic shunt,peritoneovenous shunt,automated low-flow ascites pump,cell-free and concentrated ascites reinfusion therapy,and peritoneal catheter drainage.This review introduces the advantages and disadvantages of these methods in different aspects,as well as indications and contraindications for this disease. 展开更多
关键词 Liver cirrhosis ascites Large-volume paracentesis Transjugular intrahepatic portosystemic shunt Peritoneovenous shunt Automated low-flow ascites pump Cell-free and concentrated ascites reinfusion therapy Peritoneal catheter drainage
下载PDF
Novel triple therapy for hemorrhagic ascites caused by endometriosis:A case report 被引量:1
2
作者 Xue Han Shi-Tai Zhang 《World Journal of Clinical Cases》 SCIE 2020年第23期6206-6212,共7页
BACKGROUND Massive hemorrhagic ascites caused by endometriosis is exceedingly rare,and the treatment strategy remains controversial.Here,we report a case of endometriosis with massive hemorrhagic ascites treated with ... BACKGROUND Massive hemorrhagic ascites caused by endometriosis is exceedingly rare,and the treatment strategy remains controversial.Here,we report a case of endometriosis with massive hemorrhagic ascites treated with a novel triple therapy including conservative surgery,gonadotropin-releasing hormone agonist,and then dienogest.CASE SUMMARY A 28-year-old nulliparous patient was admitted to Shengjing Hospital of China Medical University,and exploratory laparoscopy was performed.A total of 9500 mL of brown ascites was aspirated from the pelvic cavity,the bilateral ovaries strongly adhered to the posterior of the uterus and were fixed to the pelvic floor,and endometriotic cysts were not observed in either ovary.The pelvic and abdominal peritonea were covered with patchy red,white,and brown endometriotic lesions and defects.Partial surgical resection of endometriotic lesions on the peritoneum was performed while we simultaneously collected multiple peritoneal biopsies.The final pathological diagnosis was endometriosis coupled with hemorrhagic necrotic tissue.CONCLUSION Postoperative injection of gonadotropin-releasing hormone agonist was provided three times,followed by dienogest administration,and we will continue to follow up with this ongoing treatment. 展开更多
关键词 ENDOMETRIOSIS Hemorrhagic ascites Novel triple therapy DIENOGEST Recurrence Case report
下载PDF
Myxedema ascites with high CA-125:Case and a review of literature 被引量:4
3
作者 Bou Khalil Roula El Rassi Patrick +5 位作者 Chammas Nizar Obeid Jean Ghabach Maroun Sakr Charles Itani Tarek Farhat Said 《World Journal of Hepatology》 CAS 2013年第2期86-89,共4页
Ascites appearing in a previously healthy female patient is usually ascribed to a variety of causes,among which,is a cancerous process,especially if it comes with a raised CA-125 level.Although the CA-125 antigen is p... Ascites appearing in a previously healthy female patient is usually ascribed to a variety of causes,among which,is a cancerous process,especially if it comes with a raised CA-125 level.Although the CA-125 antigen is present on more than 80% of malignant epithelial ovarian tissue of non-mucinous type,it is also found on both healthy and malignant cells of mesothelial and non-mesothelial origin.Myxedema ascites which is caused by hypothyroidism is a rare entity,but on the other hand is easy to treat.It is one of the differential diagnoses when the ascites is refractory to treatment and no other obvious cause can be identified.If the diagnosis is delayed,patients will frequently receive unnecessary procedures,while treatment has very good response rates and ascites resolve with serum CA-125 normalization after adequate hormonal treatment. 展开更多
关键词 HYPOTHYROIDISM Refractory ascites HIGH CA-125 Hormonal therapy Abdominal PARACENTESIS
下载PDF
Clinical Observation on Treatment of Moderate and Severe Periodical Mastalgia with TCM Hot-wet Compress Therapy 被引量:1
4
作者 Qiao HUANG Yujian SUN +6 位作者 Na FU Fang XIE Hao DONG Wenjie ZHAO Chun WANG Huan LIANG Dongxiao ZHANG 《Medicinal Plant》 CAS 2018年第4期83-86,共4页
[Objectives] To observe the clinical therapeutic efficacy of local hot-wet compress therapy of digestion ointment prescription on the patients with moderate and severe mastalgia. [Methods] Firstly,60 patients with mas... [Objectives] To observe the clinical therapeutic efficacy of local hot-wet compress therapy of digestion ointment prescription on the patients with moderate and severe mastalgia. [Methods] Firstly,60 patients with mastalgia were selected,and divided into the experimental group and control group( 30 cases for each group). The control group was treated with acupuncture at distal point,and the experimental group was treated with TCM local hot-wet compress therapy combined with acupuncture at distal point. Then,the clinical therapeutic efficacy of two groups was compared. [Results]The experimental group was superior to the control group in relieving the breast pain,improving emotional integral,reducing breast lumps,improving lump texture,and improving TCM syndrome integral( P < 0. 05). [Conclusions]The digestion ointment prescription local hot-wet compress therapy has a significant therapeutic effect on treatment of mastalgia and can significantly improve the breast pain symptom of patients. 展开更多
关键词 Periodical mastalgia MODERATE SEVERE Hot-wet compress therapy Digestion ointment External therapy of tcm
下载PDF
Clinical Effects of the Qi-acupuncture Therapy of TCM on Portal Hypertension 被引量:1
5
作者 XU Yu-bo LIU Xiang 《World Journal of Integrated Traditional and Western Medicine》 2020年第7期1-9,共9页
Objective:To explore the effective prevention and treatment of portal hypertension(PH).Methods:A total of 220 patients who came to our hospital from March 2015 to October 2018 were treated.They were randomly divided i... Objective:To explore the effective prevention and treatment of portal hypertension(PH).Methods:A total of 220 patients who came to our hospital from March 2015 to October 2018 were treated.They were randomly divided into the treatment group and the control group,each with 110 cases.Before treatment,there was no significant differences in age,sex,clinical symptoms,signs,laboratory tests and color Doppler ultrasound related examinations between the 2 groups(P>0.05).Among them,the treatment group on the basis of traditional Chinese and Western medicine treatment in our hospital,the Qi-acupuncture therapy of TCM was added.The extra meridian acupoints along with acupoints were selected.The control group received conventional treatment with traditional Chinese and Western medicine in our hospital.Results:There were significant differences in clinical symptoms,signs and chemistry between groups after treatment(P<0.01).There were significant differences in test,color ultrasound related examination and so on(P<0.01).Those in the treatment group was significantly better than the control group(P<0.01).Conclusion:On the basis of the Qi-acupuncture therapy of TCM,selecting extra meridian acupoint and acupoints can effectively treat PH. 展开更多
关键词 Portal hypertension CIRRHOSIS Qi-acupuncture therapy of tcm ACUPUNCTURE
下载PDF
Non-pharmacological therapy of TCM for the treatment of essential hypertension
6
作者 Meng-Lei Li Shan-Fu Chen Ying-Qiang Zhao 《TMR Integrative Medicine》 2019年第10期1-10,共10页
Non-pharmacotogicat treatment is an important means to control hypertension, with many advantages such as tow cost, tess medication, stable btood pressure, tess compHcations, and improved prognosis. This article revie... Non-pharmacotogicat treatment is an important means to control hypertension, with many advantages such as tow cost, tess medication, stable btood pressure, tess compHcations, and improved prognosis. This article reviews the research progress of non-drug treatment of hypertension in Chinese medicine in the past five years, and evaluates traditional Chinese medicine such as TCM Qigong, Wuhuo opera, Ba Duanjin and Taijiquan, and Chinese medicine acupuncture, moxibustion, massage, apptication, acupoint embedding and other traditional Chinese medicine. The effect of external treatment in hypertension control provides guidance for non-drug therapy to control hypertension. 展开更多
关键词 Primary HYPERTENSION Prevention and control tcm Non-drug therapy Chinese MEDICINE external TREATMENT
下载PDF
Systematic review and meta analysis of the TCM therapy of Fuzheng and Kangai combined with chemotherapy in treating advanced NSCLC
7
作者 Fei-Ye Wang Fang Zhao +1 位作者 Wan-Yin Wu 《Journal of Hainan Medical University》 2021年第24期42-47,共6页
Objective:To systematically evaluate TCM of Fuzheng and Kangai combined with chemotherapy in the treatment of Advanced NSCLC,including the efficacy and effect on the quality of life of patients.Methods:Two researchers... Objective:To systematically evaluate TCM of Fuzheng and Kangai combined with chemotherapy in the treatment of Advanced NSCLC,including the efficacy and effect on the quality of life of patients.Methods:Two researchers independently searched the literature of clinical trails from Jan.2010 until Jun.2020 in the Cochrane Library,Pubmed,Embase,CBM,CNKI,WanFang Data and VIP database.Also,they had been evaluated and extracted strictly by REVMAN 5.3.Results:A total of 1303 patients were included in 15 articles.The meta analysis shows that the TCM of Fuzheng and Kangai combined with chemotherapy can improve the objective response rate[OR=2.14,95%CI(1.67,2.74),P<0.00001],disease control rate[OR=2.54,95%CI(1.88,3.42),P<0.00001]and KPS score[OR=3.28,95%CI(1.92,5.60),P<0.0001],decrease the incidence rate of liver injury[OR=0.34,95%CI(0.21,0.54),P=0.003],hemoglobin reduction[OR=0.53,95%CI(0.28,1.01),P=0.05],leukopenia[OR=0.22,95%CI(0.13,0.39),P<0.00001],thrombocytopenia[OR=0.32,95%CI(0.21,0.50),P<0.00001],toxic effects on the digestive systems[OR=0.30,95%CI(0.19,0.46),P<0.00001].Conclusions:the experimental group was better than control one in short-term efficacy and KPS score.Furthermore,the experimental group can reduce the incidence rate of myelosuppression,toxicity of digestive system and liver. 展开更多
关键词 tcm therapy of Fuzheng and Kangai CHEMOtherapy Small cell lung cancer Meta analysis
下载PDF
血府逐瘀汤治疗冠心病研究进展 被引量:2
8
作者 黄敏 刘水花 +3 位作者 张诗雨 石炜琦 蔡宗余 卢健棋 《光明中医》 2024年第4期831-832,F0003,F0004,共4页
冠心病是临床常见的心血管疾病之一,其发病率和病死率呈上升趋势,严重危害居民健康,加重国家经济负担。血府逐瘀汤有活血化瘀、理气止痛的功效,主治胸中血瘀证。临床上根据其功效常用于治疗血瘀证冠心病,并取得良好疗效。此文旨在对血... 冠心病是临床常见的心血管疾病之一,其发病率和病死率呈上升趋势,严重危害居民健康,加重国家经济负担。血府逐瘀汤有活血化瘀、理气止痛的功效,主治胸中血瘀证。临床上根据其功效常用于治疗血瘀证冠心病,并取得良好疗效。此文旨在对血府逐瘀汤治疗冠心病的临床运用、作用机制及研究进展展开探讨,为深入挖掘血府逐瘀汤临床及实验研究提供新思路。 展开更多
关键词 冠心病 血府逐瘀汤 中医药疗法 综述
下载PDF
八段锦联合放松功对轻中度抑郁的影响研究 被引量:1
9
作者 闫雪 汪卫东 +2 位作者 洪兰 杨扬 李玉波 《广州中医药大学学报》 CAS 2024年第2期407-413,共7页
【目的】探究中医行为心理疗法八段锦联合放松功干预轻中度抑郁的效果。【方法】将40例轻中度抑郁患者随机分为干预组和对照组,每组各20例。干预组给予八段锦锻炼联合放松功干预治疗,对照组给予西药氢溴酸西酞普兰片治疗,疗程为6周。观... 【目的】探究中医行为心理疗法八段锦联合放松功干预轻中度抑郁的效果。【方法】将40例轻中度抑郁患者随机分为干预组和对照组,每组各20例。干预组给予八段锦锻炼联合放松功干预治疗,对照组给予西药氢溴酸西酞普兰片治疗,疗程为6周。观察2组患者干预前后汉密尔顿抑郁量表(HAMD)评分、蒙哥马利抑郁量表(MADRS)评分、匹兹堡睡眠质量指数(PSQI)评分以及生活质量综合评定问卷(GQOL-74)评分的变化情况,并评价2组患者的抑郁改善疗效。【结果】(1)抑郁改善疗效方面,治疗6周后,干预组的总有效率为95.0%(19/20),对照组为90.0%(18/20),组间比较(χ2检验),差异无统计学意义(P>0.05)。(2)抑郁程度方面,治疗后,2组患者的HAMD评分和MADRS评分均较治疗前明显下降(P<0.01),但治疗后组间比较,差异均无统计学意义(P>0.05)。(3)生活质量方面,治疗后,2组患者的GQOL-74的躯体功能、心理功能、社会功能、物质生活等各项评分及总分均较治疗前明显改善(P<0.01),但治疗后组间比较,差异均无统计学意义(P>0.05)。(4)睡眠质量方面,治疗后,2组患者的PSQI的睡眠质量、入睡时间、睡眠时间、睡眠效率、睡眠障碍、催眠药物和日间功能等各项评分及总分均较治疗前明显改善(P<0.01),且干预组对PSQI的睡眠质量、入睡时间评分及总分的改善作用明显优于对照组(P<0.05)。【结论】八段锦锻炼联合放松功干预对轻中度抑郁症状的改善有明确的疗效,可以为轻中度抑郁症患者提供更广泛的选择可能,特别是对西药治疗不耐受的患者更具有一定的优势。 展开更多
关键词 八段锦 放松功 轻中度抑郁 中医行为心理疗法 生活质量 睡眠质量
下载PDF
中医药治疗特发性肺纤维化研究进展 被引量:1
10
作者 张晓磊 郭思佳 《光明中医》 2024年第7期1457-1458,F0003,F0004,共4页
特发性肺纤维化是原因不明的慢性进行性致纤维化间质性肺炎,主要见于中老年男性,局限于肺,临床上呈渐进性呼吸困难和肺功能恶化,组织病理学和胸部HRCT表现为特征性的寻常型间质性肺炎。特发性肺纤维化属中医学“肺痿、肺痹”范畴,中医... 特发性肺纤维化是原因不明的慢性进行性致纤维化间质性肺炎,主要见于中老年男性,局限于肺,临床上呈渐进性呼吸困难和肺功能恶化,组织病理学和胸部HRCT表现为特征性的寻常型间质性肺炎。特发性肺纤维化属中医学“肺痿、肺痹”范畴,中医对此病的认识历史悠久,优势明显,近年来受到越来越多的重视,通过对近5年多(2018年—至今)中医药在特发性肺纤维化的研究文献进行总结,主要从病机(“肺虚络瘀”论、“热毒滞络”论、“肺寒络凝”论、其他)、临床研究(古方、自拟方、中成药、六字诀呼吸操、热敏灸)2方面进行了综述,以期为此病的治疗提供有益的参考。 展开更多
关键词 肺痿 特发性肺纤维化 中医药疗法 综述
下载PDF
中医特色疗法在肝硬化腹水防治中的应用及机制研究进展
11
作者 杨培伟 刘光伟 +1 位作者 赵文霞 马素平 《世界中医药》 CAS 北大核心 2024年第12期1865-1869,共5页
肝硬化腹水是肝硬化失代偿期最常见的并发症之一,也是疾病进展的重要标志。目前西医对此尚无特效的治疗方法,而中医特色疗法在本病治疗或辅助治疗中具有确切的疗效。通过总结近10年来中医特色疗法在肝硬化腹水中的应用和作用机制研究,... 肝硬化腹水是肝硬化失代偿期最常见的并发症之一,也是疾病进展的重要标志。目前西医对此尚无特效的治疗方法,而中医特色疗法在本病治疗或辅助治疗中具有确切的疗效。通过总结近10年来中医特色疗法在肝硬化腹水中的应用和作用机制研究,指出目前临床应用和机制研究中存在的问题,为进一步临床应用和机制研究提供思路和方向。 展开更多
关键词 肝硬化腹水 中医特色疗法 临床运用 机制研究
下载PDF
隐性听力损失中医病机及防治研究进展
12
作者 曲中源 石磊 +1 位作者 冷辉 孙海波 《中华中医药学刊》 CAS 北大核心 2024年第2期46-50,共5页
隐性听力损失是以纯音听阈正常,噪声背景下言语识别能力降低为主要症状的疾病,噪声暴露、药物损伤、年龄老化是主要的致病危险因素,其发病隐匿,容易忽视,危险因素持续暴露可造成不可逆听力损伤,目前临床多无有效的治疗方法,以早期预防... 隐性听力损失是以纯音听阈正常,噪声背景下言语识别能力降低为主要症状的疾病,噪声暴露、药物损伤、年龄老化是主要的致病危险因素,其发病隐匿,容易忽视,危险因素持续暴露可造成不可逆听力损伤,目前临床多无有效的治疗方法,以早期预防为主。根据隐性听力损失的致病因素及发病机制,探讨隐性听力损失的中医病机,认为脾虚湿滞、清窍蒙蔽、肾元不足、邪聚耳窍为致病的内在因素,毒邪犯耳、内毒留滞、毒瘀经络为病理机制,并对近年来隐性听力损失的预防与治疗研究概况做一总结,为中医药治疗隐性听力损失研究提供理论依据和临床经验。 展开更多
关键词 隐性听力损失 病机 中医疗法 研究进展
下载PDF
辨证施护联合热敏灸治疗肝硬化腹水临床观察
13
作者 熊萍 朱克妹 +1 位作者 黎明霞 于长振 《中国中医药现代远程教育》 2024年第15期162-164,共3页
目的探究中医辨证施护联合热敏灸治疗肝硬化腹水的临床效果。方法选择肝硬化腹水患者60例,分为对照组(予常规治疗)和试验组(予热敏灸联合中药治疗),对比两组临床疗效及不良反应发生率。结果试验组治疗总有效率为96.67%(29/30),高于对照... 目的探究中医辨证施护联合热敏灸治疗肝硬化腹水的临床效果。方法选择肝硬化腹水患者60例,分为对照组(予常规治疗)和试验组(予热敏灸联合中药治疗),对比两组临床疗效及不良反应发生率。结果试验组治疗总有效率为96.67%(29/30),高于对照组的83.33%(25/30),差异有统计学意义(P<0.05)。对照组不良反应发生率为6.67%(2/30),而试验组患者未出现不良反应,差异有统计学意义(P<0.05)。结论中医辨证施护联合热敏灸治疗肝硬化腹水效果显著、安全高,值得临床推广应用。 展开更多
关键词 臌胀 肝硬化腹水 中医辨证施护 热敏灸疗法 中医综合疗法
下载PDF
调补脾肾中药复方治疗原发性骨质疏松症临床研究
14
作者 张玉 孙玉凤 +2 位作者 高志红 焦丽静 赵会琪 《河北中医药学报》 2024年第4期19-22,44,共5页
目的:观察调补脾肾中药复方治疗原发性骨质疏松症(primary osteoporosis,POP)的临床疗效。方法:POP患者共计60例,采用随机数字表法随机分为对照组(30例)和治疗组(30例)。对照组治疗方法为常规综合治疗,治疗组治疗方法为在对照组的基础... 目的:观察调补脾肾中药复方治疗原发性骨质疏松症(primary osteoporosis,POP)的临床疗效。方法:POP患者共计60例,采用随机数字表法随机分为对照组(30例)和治疗组(30例)。对照组治疗方法为常规综合治疗,治疗组治疗方法为在对照组的基础上加用调补脾肾中药复方。比较2组患者的骨密度、血清碱性磷酸酶(ALP)、血红蛋白(Hb)、白蛋白(ALB)、血钙(Ca)、血磷(P)及临床疗效。结果:治疗组总有效率高于对照组(P<0.05)。治疗后,2组的ALP水平均降低,治疗组低于对照组(P<0.05),Hb、ALB水平及骨密度均提高,三个指标相比较治疗组高于对照组(P<0.05)。结论:POP用调补脾肾中药复方治疗效果明确,能有效调节ALP、Hb、ALB水平,提高骨密度。 展开更多
关键词 原发性骨质疏松症 中药疗法 疗效
下载PDF
中医外治法治疗痛风性关节炎研究文献可视化分析
15
作者 金芳梅 李浩林 +5 位作者 阚丽丽 陈平 杨娟娟 张旭明 杨天宁 王海东 《中国中医药图书情报杂志》 2024年第1期158-163,共6页
目的 分析中医外治法治疗痛风性关节炎相关文献,了解该领域研究现状、研究热点和发展趋势,为该领域后续研究提供研究思路。方法 检索中国知识资源总库(CNKI)、中国学术期刊数据库(万方数据)、中文科技期刊数据库(VIP)2000年1月1日-2022... 目的 分析中医外治法治疗痛风性关节炎相关文献,了解该领域研究现状、研究热点和发展趋势,为该领域后续研究提供研究思路。方法 检索中国知识资源总库(CNKI)、中国学术期刊数据库(万方数据)、中文科技期刊数据库(VIP)2000年1月1日-2022年11月30日收录的中医外治法治疗痛风性关节炎研究文献,利用NoteExpress3.6.0软件对文献进行人工筛选,借助Excel2019绘制发文趋势图和期刊分布图;采用VOSviewer1.6.18软件绘制核心作者合作网络、机构合作密度视图和关键词共现图谱,使用CiteSpace6.1.R4软件绘制关键词聚类分析图、时间线图及关键词突现图谱,并对以上内容进行分析。结果 共纳入1 304篇文献,发文量总体呈增长态势;纳入文献涉及318本期刊、2 890位作者,发文量最多的是广州中医药大学;分析得出文献关键词1 181个,形成12个有意义的聚类,并展现出了湿热蕴结型、炎性因子、中医药疗法等20个突现词。结论 中医外治法治疗痛风性关节炎的研究热点主要集中于中药内服外敷、临床疗效观察及中药外敷、针刺、刺血疗法、电针、火针、针刀等中医外治法,备受关注的中医证型是湿热蕴结型。 展开更多
关键词 中医外治法 痛风性关节炎 VOSviewer CITESPACE 研究热点
下载PDF
王海东主任医师治疗强直性脊柱炎临床经验思辨
16
作者 苏小军 朱文菊 +6 位作者 田雪梅 李伟青 吕有强 杨会军 王欢 何倩 王海东(指导) 《西部中医药》 2024年第10期19-22,共4页
王海东主任医师认为强直性脊柱炎属本虚标实之证,以肝肾亏虚、气血不足、脾胃虚弱为本,寒、湿、瘀等实邪偏盛为标。王海东主任医师主张分期分型辨证论治,巧用药对并全程注重调护脾胃。
关键词 强直性脊柱炎 中医药治疗 名医经验 本虚标实
下载PDF
芪葛威灵胶囊治疗糖尿病周围神经病变临床观察
17
作者 闫冬雪 孟永杰 +3 位作者 郭晓霏 杨丽丽 刘亚丽 郭俊杰 《山西中医》 2024年第6期23-25,共3页
目的:观察芪葛威灵胶囊治疗气阴两虚兼血瘀型糖尿病周围神经病变患者的临床疗效。方法:选取120例气阴两虚兼血瘀型糖尿病神经病变患者,按随机数字表法分为两组各60例。治疗组予芪葛威灵胶囊治疗,对照组予甲钴胺片口服。治疗8周后,比较... 目的:观察芪葛威灵胶囊治疗气阴两虚兼血瘀型糖尿病周围神经病变患者的临床疗效。方法:选取120例气阴两虚兼血瘀型糖尿病神经病变患者,按随机数字表法分为两组各60例。治疗组予芪葛威灵胶囊治疗,对照组予甲钴胺片口服。治疗8周后,比较两组患者临床疗效、中医证候积分、多伦多临床评分系统(TCSS)评分、神经传导速度、不良反应等。结果:治疗组总有效率91.67%,优于对照组的68.33%(P﹤0.05);治疗后,两组患者肢体麻木、疼痛及小腿抽搐证候积分均明显下降(P﹤0.05),两组TCSS评分均明显降低(P﹤0.05),腓总神经、胫后神经运动神经传导速度均明显提高(P﹤0.05),且治疗组改善程度均优于对照组(P﹤0.05)。结论:芪葛威灵胶囊可改善气阴两虚兼血瘀型糖尿病周围神经病变患者的临床症状,提高TCSS评分、改善神经传导速度,临床疗效良好。 展开更多
关键词 芪葛威灵胶囊 糖尿病周围神经病变 中医药疗法
下载PDF
七味白术散加味治疗肝硬化腹泻临床观察
18
作者 任燕怡 李霞 +2 位作者 冯培民 何俊余 马悦 《山西中医》 2024年第4期16-18,共3页
目的:观察七味白术散加味治疗肝硬化腹泻的临床疗效。方法:选取确诊的96例肝硬化腹泻患者,随机分为两组各48例。两组均予肝硬化西医常规治疗,对照组在此基础上予双歧杆菌四联活菌口服,治疗组予七味白术散加味治疗,疗程均为2周,比较两组... 目的:观察七味白术散加味治疗肝硬化腹泻的临床疗效。方法:选取确诊的96例肝硬化腹泻患者,随机分为两组各48例。两组均予肝硬化西医常规治疗,对照组在此基础上予双歧杆菌四联活菌口服,治疗组予七味白术散加味治疗,疗程均为2周,比较两组临床疗效以及肠道sIgA水平变化、肠道菌群的改善情况。结果:治疗组总有效率为95.83%,对照组总有效率81.25%,两组比较差异有统计学意义(P﹤0.05);治疗后,治疗组患者的ALT、AST、TBIL改善程度明显优于对照组(P﹤0.05);治疗组肠道sIgA水平、肠道菌群改善水平均明显优于对照组(P﹤0.05)。结论:七味白术散加味治疗肝硬化腹泻疗效较好,可改善患者肝功能水平及肠道有益菌群生长,增加患者肠道sIgA水平。 展开更多
关键词 肝硬化 腹泻 七味白术散 中医药疗法
下载PDF
巴芪除痒止咳方治疗肺肾两虚兼风寒犯肺型咳嗽变异性哮喘疗效观察
19
作者 张旺生 陈慧 +6 位作者 林秀明 陈成 陈永忠 林巧云 黄依晴 黄月云 李希 《山西中医》 2024年第6期10-12,共3页
目的:观察巴芪除痒止咳方治疗肺肾两虚兼风寒犯肺型咳嗽变异性哮喘的临床疗效。方法:选取门诊60名咳嗽变异性哮喘患者,随机分为两组各30例。对照组予布地奈德/福莫特罗粉吸入剂治疗,治疗组在对照组基础上予巴芪除痒止咳方治疗,疗程2周... 目的:观察巴芪除痒止咳方治疗肺肾两虚兼风寒犯肺型咳嗽变异性哮喘的临床疗效。方法:选取门诊60名咳嗽变异性哮喘患者,随机分为两组各30例。对照组予布地奈德/福莫特罗粉吸入剂治疗,治疗组在对照组基础上予巴芪除痒止咳方治疗,疗程2周。比较两组临床疗效,VAS、CET、FeNO评分及中医证候积分变化情况。结果:治疗后,治疗组总有效率96.67%,高于对照组的80.00%,两组比较差异具有统计学意义(P﹤0.05);两组VAS、CET及FeNO评分均得到了改善(P﹤0.05),且治疗组VAS、CET评分较对照组改善更明显;治疗后治疗组咳痰、咽痒、恶风、自汗积分均小于对照组(P﹤0.05)。结论:巴芪除痒止咳方能减轻肺肾两虚兼风寒犯肺型咳嗽变异性哮喘患者气道炎症反应,缓解临床症状。 展开更多
关键词 咳嗽变异性哮喘 巴芪除痒止咳方 中医药疗法
下载PDF
益髓生血膏辅助治疗结直肠癌术后化疗患者临床观察
20
作者 武珊珊 刘敏 +2 位作者 渠红 宋志强 谢枫 《山西中医》 2024年第11期25-26,共2页
目的:观察益髓生血膏对结直肠癌患者术后化疗所致骨髓抑制的影响。方法:选取结直肠癌术后进行化疗的患者102例,采用随机数字表法分为两组各51例。对照组予XELOX方案(奥沙利铂联合卡培他滨)化疗;治疗组在对照组基础上联合使用益髓生血膏... 目的:观察益髓生血膏对结直肠癌患者术后化疗所致骨髓抑制的影响。方法:选取结直肠癌术后进行化疗的患者102例,采用随机数字表法分为两组各51例。对照组予XELOX方案(奥沙利铂联合卡培他滨)化疗;治疗组在对照组基础上联合使用益髓生血膏。以3周为1个周期,共进行6个周期的治疗。比较两组治疗前后骨髓抑制情况、卡氏功能评分(KPS)和生活质量(QLQ-CR38)评分情况。结果:第6周期化疗后,治疗组骨髓抑制发生率(80.39%)较对照组(100%)明显下降(P﹤0.05),治疗组KPS评分、QLQ评分均较对照组升高(P﹤0.05)。结论:益髓生血膏辅助治疗结直肠癌术后化疗患者疗效较好,可明显降低骨髓抑制发生率,维持并提高患者生活质量,减少化疗不良反应。 展开更多
关键词 结直肠癌 益髓生血膏 中医药疗法
下载PDF
上一页 1 2 250 下一页 到第
使用帮助 返回顶部